HCA Healthcare price target raised to $285 from $240 at Loop Capital

Loop Capital analyst Joseph France raised the firm’s price target on HCA Healthcare to $285 from $240 and keeps a Buy rating on the shares. The company’s Q4 results were "solid" and its 2024 growth should return to more normal long-term trends after enduring headwinds in 2023, the analyst tells investors in a research note. The firm also states that it was impressed with the company’s progress on staffing, where a quick fix could accelerate HCA’s recovery from the pandemic.